下载亿题库APP
联系电话:400-660-1360
请谨慎保管和记忆你的密码,以免泄露和丢失
请谨慎保管和记忆你的密码,以免泄露和丢失
2021年考研初试备考还有最后的两个多月时间,相信大家也都在紧张的复习当中。在复习时,多做练习题可以让我们更加了解考试内容。下面,帮考网为大家带来考研初试的一些模拟试题,正在备考的小伙伴赶紧练起来吧。
At 18, Ashanthi DeSilva of suburban Cleveland is a living symbol of one of the great intellectual achievements of the 20th century. Born with an extremely rare and usually fatal disorder that left her without a functioning immune system (the “bubble-boy disease,” named after an earlier victim who was kept alive for years in a sterile plastic tent), she was treated beginning in 1990 with a revolutionary new therapy that sought to correct the defect at its very source, in the genes of her white blood cells. It worked. Although her last gene-therapy treatment was in 1992, she is completely healthy with normal immune function, according to one of the doctors who treated her, W. French Anderson of the University of Southern California. Researchers have long dreamed of treating diseases from hemophilia to cancer by replacing mutant genes with normal ones. And the dreaming may continue for decades more. “There will be a gene-based treatment for essentially every disease,” Anderson says, “within 50 years.”
It\'s not entirely clear why medicine has been so slow to build on Anderson\'s early success. The National Institutes of Health budget office estimates it will spend $432 million on gene-therapy research in 2005, and there is no shortage of promising leads. The therapeutic genes are usually delivered through viruses that don\'t cause human disease. “The virus is sort of like a Trojan horse,” says Ronald Crystal of New York Presbyterian/Weill Cornell Medical College. “The cargo is the gene.”
At the University of Pennsylvania\'s Abramson Cancer Center, immunologist Carl June recently treated HIV patients with a gene intended to help their cells resist the infection. At Cornell University, researchers are pursuing gene-based therapies for Parkinson\'s disease and a rare hereditary disorder that destroys children\'s brain cells. At Stanford University and the Children\'s Hospital of Philadelphia, researchers are trying to figure out how to help patients with hemophilia who today must inject themselves with expensive clotting drugs for life. Animal experiments have shown great promise.
But somehow, things get lost in the translation from laboratory to patient. In human trials of the hemophilia treatment, patients show a response at first, but it fades over time. And the field has still not recovered from the setback it suffered in 1999, when Jesse Gelsinger, an 18-year-old with a rare metabolic disorder, died after receiving an experimental gene therapy at the University of Pennsylvania. Some experts worry that the field will be tarnished further if the next people to benefit are not patients but athletes seeking an edge. This summer, researchers at the Salk Institute in San Diego said they had created a “marathon mouse” by implanting a gene that enhances running ability; already, officials at the World Anti-Doping Agency are preparing to test athletes for signs of “gene doping.” But the principle is the same, whether you\'re trying to help a healthy runner run faster or allow a muscular-dystrophy patient to walk. “Everybody recognizes that gene therapy is a very good idea,” says Crystal. “And eventually it\'s going to work.”
1. The case of Ashanthi Desilva is mentioned in the text to ____________.
[A] show the promise of gene-therapy
[B] give an example of modern treatment for fatal diseases
[C] introduce the achievement of Anderson and his team
[D] explain how gene-based treatment works
2. Anderson‘s early success has ________________.
[A] greatly speeded the development of medicine
[B] brought no immediate progress in the research of gene-therapy
[C] promised a cure to every disease
[D] made him a national hero
3. Which of the following is true according to the text?
[A] Ashanthi needs to receive gene-therapy treatment constantly.
[B] Despite the huge funding, gene researches have shown few promises.
[C] Therapeutic genes are carried by harmless viruses.
[D] Gene-doping is encouraged by world agencies to help athletes get better scores.
4. The word “tarnish” (line 5, paragraph 4) most probably means ____________.
[A] affect
[B] warn
[C] trouble
[D] stain
5. From the text we can see that the author seems ___________.
[A] optimistic
[B] pessimistic
[C] troubled
[D] uncertain
答案:A B C D A
以上就是帮考网为大家带来的全部内容,希望能给大家一些帮助。帮考网提醒:以上内容仅为参考,在做试题练习时,小伙伴们还是要以考研大纲为准,有针对性的去做题哦。最后,帮考网预祝参加2021年考研初试的小伙伴都能取得优异的成绩。
在职研究生和全日制研究生入学考试的内容一样吗?:在职研究生和全日制研究生入学考试的内容一样吗?在职研究生和全日制研究生一起考试,试卷相同,所以考试内容也是一样的,不同的就是录取分数线和上课形式。
以前年度的普通研究生入学考试成绩还能查询吗?:以前年度的普通研究生入学考试成绩还能查询吗?以前的考研成绩能查,成绩查询可以登录中国研究生招生信息网,根据自己报考研究生考试的报名号登陆,即可查询以前的考研成绩。
研究生入学考试要考哪几门?:研究生入学考试要考哪几门?(1)初试是每年1月份全国统考,考试科目分为政治(满分100)、外语(满分100)、专业课一(如数学)、专业课二。公共课包含政治、外语、数学,由全国统一命题。专业课由各学校自主命题。有些专业课统一命题进行联考。有的专业不考数学,考由学校命题的两门专业课。(2)复试分为面试和笔试,学校专业不同,科目形式设置会有不同。
2020-06-06
2020-06-06
2020-06-06
2020-06-06
2020-06-06
微信扫码关注公众号
获取更多考试热门资料